MarkMHuthMDPhD, FACC

Cardiology • Medford, OR

Echocardiography, Heart Failure & Transplantation, Clinical Informatics

Physician

Join to view full profile

Dr. Huth is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Huth's full profile

Already have an account?

Office
520 Medical Center Dr
Ste 200
Medford, OR 97504
Phone+1 541-282-6600

Fax+1 541-282-6601
Is this information wrong?

Education & Training

University of WashingtonFellowship, Cardiovascular Disease, 1989 - 1992
Louisiana State University School of MedicineResidency, Internal Medicine, 1986 - 1988
Louisiana State University School of Medicine in New OrleansClass of 1985

Certifications & Licensure

OR State Medical License 1994 - 2025
CA State Medical License 1995 - 2024
WA State Medical License 1989 - 1995
LA State Medical License 1986 - 1992
American Board of Internal Medicine Cardiovascular Disease

Awards, Honors, & Recognition

Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2012
Fellow (FACC) American College of Cardiology

Clinical Trials

COBRA PZF™ Coronary Stent for Early Healing, Thrombus Inhibition, Endothelialization and Avoiding Long-Term DAPT Start of enrollment: 2013 Aug 21
Completed
Not Applicable

Publications & Presentations

PubMed

9 citations
Correlation of waist to hips ratio to the prevalence of diabetes and hypertension in black females.
F. Svec, M. Rivera, M. Huth> ;Journal of the National Medical Association. 1990 Apr 1
27 citations
9-Month Clinical and Angiographic Outcomes of the COBRA Polyzene-F NanoCoated Coronary Stent System
Donald E. Cutlip, Kirk N. Garratt, Victor Novack, Mark Barakat, Perwaiz Meraj, Luc Maillard, Andrejs Erglis, Rajiv Jauhar, Jeffrey J. Popma, Robert C. Stoler, Sigmund ...> ;JACC. Cardiovascular Interventions. 2017 Jan 23
Angiotensin Receptor-Neprilysin Inhibition in Acute Myocardial Infarction.
Pfeffer MA, Claggett B, Lewis EF, Granger CB, Køber L, Maggioni AP, Mann DL, McMurray JJV, Rouleau JL, Solomon SD, Steg PG, Berwanger O, Cikes M, De Pasquale CG, East ...> ;The New England journal of medicine.
Ticagrelor in Patients with Stable Coronary Disease and Diabetes.
Steg PG, Bhatt DL, Simon T, Fox K, Mehta SR, Harrington RA, Held C, Andersson M, Himmelmann A, Ridderstråle W, Leonsson-Zachrisson M, Liu Y, Opolski G, Zateyshchikov D...> ;The New England journal of medicine. 2019-09-01
Ticagrelor in patients with diabetes and stable coronary artery disease with a history of previous percutaneous coronary intervention (THEMIS-PCI): a phase 3, placebo-...
Bhatt DL, Steg PG, Mehta SR, Leiter LA, Simon T, Fox K, Held C, Andersson M, Himmelmann A, Ridderstråle W, Chen J, Song Y, Diaz R, Goto S, James SK, Ray KK, Parkhomenk...> ;Lancet (London, England). 2019-09-01
22 citations
Thiamine deficiency in congestive heart failure
Wayne C. Levy, Laurie A. Soine, Mark M. Huth, Daniel P. Fishbein> ;The American Journal of Medicine. 1992 Dec 1
6 citations
Aortic Valvular Fibroma as a Source of Systemic Emboli in POEMS Syndrome
Mark M. Huth, David Gordon, Edward D. Verrier, Catherine M Otto> ;Journal of the American Society of Echocardiography. 1991 Jul 1
Join now to see all